Table 4.
Incidences of Comamonas spp. infection from 2000 to 2022. Main characteristics of the case reports.
| Author (Ref.) | Year | Sex/Age | Country | Co-Morbidity | Type of Infection | Susceptible to * | Resistance to * | Antibiotic Treatment | Outcome |
|---|---|---|---|---|---|---|---|---|---|
| Sonnenwirth, 1970 [102] | 1970 | F/71 yr old | USA | Rheumatic heart disease | Endocarditis | Chloramphenicol, Oxytetracycline Tetracycline |
Ampicillin, Cephalothin, Colistin, Penicillin, Streptomycin | Penicillin | Full recovery |
| Isotalo et al., 2000 [103] Comamonas spp. | 2000 | M/35 yr old | Canada | None | Tenosynovitis (From an animal bite) | N/A | N/A | Intravenous (IV) cefazolin at 1 g/8 h and gentamicin 80 mg/8 h for a total of 72 h | Full recovery |
| Kaeuffer et al., 2018 [104] Comamonas aquatica | 2017 | M/66 yr old | France | Diabetes, ischemic heart disease, removed sigmoid polyps | Bacteremia and septic shock | Amoxicillin-Clavulanic acid, Ceftazidime, Cefepime, Ciprofloxacin, Imipenem, Piperacillin-Tazobactam | N/A | Norepinephrine, Cefotaxime, Ciprofloxacin (10 days) | Full recovery |
| Guo et al., 2021 [105] Comamonas thiooxydans | 2021 | F/60 yr old | China | Kidney stones. | Urinary Tract Infection | Chloramphenicol, Imipenem, SXT | Amikacin, Aztreonam, Ceftazidime, Cefepime Ciprofloxacin, Gentamicin, Levofloxacin | Imipenem-cilastatin 1 g IV for 1 month to fight | Full recovery |
F—Female, M—Male, N/A—Not Available, SXT sulfamethoxazole-trimethoprim. * Antibiotic susceptibility testing was carried out using a variety of methods including disk diffusion testing, agar and broth dilution testing and E-testing methods.